a public good project by the
Synthesis
Company
of California

© 2026

F. Rolland | doi.page

0 works0 citations0 h-index

F. Rolland

Institut de Cancérologie de l'Ouest(FR)Centre Hospitalier de Cannes(FR)

Publications by Year

Research Areas

Head and Neck Cancer Studies, Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, Prostate Cancer Treatment and Research, Lung Cancer Research Studies

Most-Cited Works

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.(1998)
→ Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): Preliminary results of the randomized phase II TREMPLIN study(2009)80 cited
→ LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial(2021)78 cited
→ Efficacy of lapatinib in patients with high tumor EGFR expression: Results of a phase III trial in advanced renal cell carcinoma (RCC)(2006)58 cited
→ Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck(2004)41 cited
→ An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck(1998)38 cited

→ Photodynamic Therapy for Subfoveal Classic Choroidal Neovascularization Related to Punctate Inner Choroidopathy (PIC) or Presumed Ocular Histoplasmosis-Like Syndrome (POHS-Like)(2005)

35 cited

[Cutaneous ulcer from Mycobacterium ulcerans. Apropos of 1 case in French Guiana].(1992)

→ Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet’s syndrome: the concept of neutrophilic disease(2013)22 cited

→ Biomarker potential of EGFR gene copy number by FISH in the phase III EXTREME study: Platinum-based CT plus cetuximab in first-line R/M SCCHN(2009)22 cited